A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...
Comprehensive Assay Portfolio: Beyond traditional chemiluminescence applications, it supports advanced diagnostics for specialized conditions such as stroke, Alzheimer's disease, thrombosis ...
The US Food and Drug Administration (FDA) has cleared Revvity’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. The authorisation by the agency marks the first ...
The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...
These chemiluminescent, no-wash assays are ideally ... advantageously with conventional enzyme-linked immunosorbent assay (ELISA). ELISA is the most widely used detection platform for the ...
The global immunodiagnostics market size is calculated at USD 24.20 billion in 2025 and is expected to reach around USD 70.9 ...
Fapon at Medlab Middle East 2025: Advancing Local Diagnostic Industry through One-stop IVD Solutions
Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest ...
The FDA cleared Euroimmun's automated chemiluminescence-based immunoassay test for free testosterone, said Revvity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results